Stay updated on Pembrolizumab Combo in ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in ES-SCLC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in ES-SCLC Clinical Trial page
- Check7 days agoChange DetectedThe location entry for Vienna was updated from 'Vienna, Vienna, Austria, 1140' to 'Vienna, State of Vienna, Austria, 1140', and the page revision changed from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAdded the disease term Small cell lung carcinoma and the Genetic and Rare Diseases Information Center as a resources entry.SummaryDifference0.1%

- Check35 days agoChange DetectedStudy protocol revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check50 days agoChange Detected- Revision: v3.4.3 has been added and Revision: v3.4.2 has been removed.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 on the page; this is a minor version change with no impact on core content — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check79 days agoChange DetectedSite revision updated from v3.4.0 to v3.4.1; no changes to page content or layout are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in ES-SCLC Clinical Trial page.